Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Successful introduction of EndoDrill GI at University Hospital Center Sestre Milosrdnice in Zagreb, Croatia

The cancer diagnostics company BiBBInstruments AB ("BiBB"), the developer of the world's first market-cleared electric-driven biopsy instrument for endoscopy, announces that the University Hospital Center Sestre Milosrdnice in Zagreb, Croatia, has started a clinical evaluation with EndoDrill[®] GI. This makes the hospital the first in southern Europe to test EndoDrill[®] GI. Dr. Tajana Pavic, Head of Interventional Gastroenterology Unit, performed the patient cases.The EndoDrill[®] GI instrument provided high-quality core tissue biopsies in all four patient cases, including three solid

Cary Group announces new initiatives to promote equality and diversity in the workplace

Cary Group, a leading provider of automotive glass repair and replacement services, is proud to announce a series of new initiatives aimed at promoting gender equality and diversity within the company. These initiatives are part of Cary Group’s ongoing commitment to creating an inclusive work environment and lowering barriers for women to enter traditionally male-dominated roles. One of these initiatives is a Female Technician Summit, held for the first time in Stockholm on August 28-29th.Cary Group is dedicated to offering a workplace with equal opportunities and an inclusive environment.

AskGamblers Kicks Off Charity Month by Donating €106,500 to HISBAS

During this year’s Charity Night, AskGamblers raised €106,500, thanks to their partners who auctioned for paid positions on the website. The funds raised on 12 June are now being donated to the Hydrocephalus and Spina Bifida Association of Serbia (HISBAS).Every year, AskGamblers hosts a Charity Night as part of AskGamblers Awards, during which the company’s partners auction for paid positions on the website. On 12 June, AskGamblers raised a record-breaking €106,500, thanks to their partners’ auctions and generosity. As Charity Month 2024 kicks off, the entire sum raised during Charity

DOF Group ASA - Decommissioning Services Contract Award in APAC

DOF is pleased to announce a contract award for subsea decommissioning services in APAC. The contract award includes project management, engineering, logistics support and execution of decommissioning activities utilising Skandi Hercules. The offshore campaign will be conducted in Western Australian waters and is expected to commence in Q4 2024 for approximately 50 days. Mons Aase, CEO DOF Group ASA, said, “This award secures further backlog for the APAC region and we look forward to delivering a safe and successful project.” The value of the contract is Limited, which DOF defines

First batch of Westinghouse fuel loaded at Fortum’s Loviisa nuclear power plant

FORTUM CORPORATION PRESS RELEASE 2.9.2024 The first batch of Westinghouse Electric Company nuclear fuel has been loaded into Fortum’s Loviisa Nuclear Power Plant during its annual outage in August. The loading of the new fuel is a significant milestone that guarantees a reliable Western alternative for fuel deliveries to the Loviisa power plant. In November 2022, Fortum signed an agreement with Westinghouse for the design, licensing and supply of a new fuel type for the Loviisa Nuclear Power Plant. During the annual outages in 2023, one test element manufactured by Westinghouse, which

Impilo acquires Qufora in partnership with existing shareholders

September 2nd, 2024 Copenhagen, Denmark.The investment company Impilo is now the majority shareholder in the Danish medtech company Qufora, which produces clinical aids for patients with chronic bowel conditions. This partnership will enable Qufora to accelerate its international expansion.   In just 18 years, Qufora has established itself as a significant international player in the market for innovative aids in gastroenterology and urology. The company, headquartered in Allerød, Denmark, is currently represented in a range of international markets, with a particular focus on the

Total Voting Rights

2 September 2024 RIGHTMOVE PLC (the Company) TOTAL VOTING RIGHTS   In accordance with the Disclosure Guidance and Transparency Rule 5.6.1, we notify the market that, as at 31 August 2024, the Company's issued share capital consisted of 800,152,291 ordinary shares of 0.1p each (Shares) of which 11,401,687 Shares are held by the Company in treasury.  The total number of voting rights in the Company as at 31 August 2024 is therefore 788,750,604 (Total Voting Rights). The Total Voting Rights figure may be used by shareholders as the denominator to determine if they are

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 191 – 2 SEPTEMBER 2024 Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 171/24 and 173/24, respectively. Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Martin Badsted, Chief Financial

Xoma AB and Dutch Seaweed Group Enter into Collaboration for the Development of a New Seaweed Cultivation Facility with Planned Delivery in 2025

Xoma AB, a leading Foodtech company with innovative solutions in seaweed cultivation, has entered into a Letter of Intent (LoI) with Dutch Seaweed Group, a company specializing in cultivating and selling seaweed. The collaboration focuses on developing and delivering an advanced seaweed cultivation facility based on Xoma's unique CLAS technology, with planned delivery in the fall of 2025.   Establishing the Future of Seaweed Cultivation Xoma AB and Dutch Seaweed Group share the vision of contributing to a more sustainable future through large-scale and efficient seaweed cultivation.

Dampskibsselskabet NORDEN A/S – weekly report on share buy-back

ANNOUNCEMENT NO. 190 – 2 SEPTEMBER 2024   On 9 August 2024, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 9 August 2024 up to and including no later than 23 October 2024. For details, please see announcement no. 171 of 8 August 2024.   Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 14 million (approximately DKK 95

2020 Bulkers Ltd. (2020) – Commencement of employment and grant of share options

Oslo, Norway, September 2, 2024 2020 Bulkers is pleased to announce that Lars-Christian Svensen has commenced as Chief Commercial Officer on September 1, 2024, as well as Chief Commercial Officer of Himalaya Shipping Ltd, under the management agreement between 2020 Bulkers Management AS and Himalaya Shipping Ltd. The Board of Directors of 2020 Bulkers has approved a long-term incentive plan which includes a grant of 80,000 share options, each of which gives the holder the right to purchase one share in the Company at an exercise price of US$16.7 per share. The exercise price will be

Cessatech and Proveca partnership - Q&A

Selected top 10 investor questionsOn 2 September – Cessatech A/S (“Cessatech” or “the Company”) releases a short Question and Answers (Q&A) overview, based on the positive feedback and questions received from investors following the agreement with Proveca on CT001. 1. How many potential partners have you had dialogue with for Europe?A: We have had several discussions with 6-7 companies, and the process has taken longer than expected. It was not until our meetings with Proveca that we felt confident about finding the best match for our objectives and aspirations. 2. What are your

Pre-Stabilisation Period Announcement

1. Pre-Stabilisation Period Announcement 2 September 2024 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. European Stability Mechanism / ISIN EU000A1Z99U9 Pre-stabilisation Period Announcement Landesbank Baden-Württemberg (contact: Lea-Marie Reich; telephone: +49 711 12727091) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/

Aptahem comments on interesting data after finalised phase 1 study

Aptahem AB (publ), a biotechnology company developing treatments for patients suffering from acute inflammatory diseases such as sepsis, today announced that the completed double-blind randomised placebo-controlled phase 1 study in healthy volunteers also showed indications of drug efficacy.1. Aptahem has summarised and concluded all additional analyses taking into account the recently completed phase 1 study. 2. At dosing, interesting immunological marker responses were noted in the subjects, prompting further analyses and evaluation of safety and mechanism of action. 3. The analyses

Major shareholder announcement

Company announcement No. 566, 2024In accordance with Section 30 of the Capital Markets Act, it is hereby announced that Invesco Ltd., UK, on 30 August 2024 informed H+H International A/S that it as of 29 August 2024 through the Invesco group had increased its holding of shares in H+H International A/S to a total of 875,683 shares equal to 5.3% of the total share capital and voting rights in H+H International A/S, thereby exceeding the major shareholder threshold of 5% as outlined in Section 38 of the Capital Markets Act.

Grants awarded under Aker BP's Long-Term Incentive Programme

Aker BP’s Long-Term Incentive Programme (LTIP) is designed to incentivise the executive management team (EMT) to deliver on the company’s long-term business objectives and maximise alignment with shareholder value creation. The LTIP is a share-based scheme in which grants are awarded annually, vested over a three-year period, and subject to a one-year lockup. Each grant represents one underlying share, and the number of grants awarded corresponds to 20 percent of base salary divided by the Aker BP share price at the time of the award. The final number of shares awarded at the end of

BioStock: BioInvent anticipates a continued data-rich 2024

With cash reserves surpassing one billion SEK, providing significant operational flexibility, and anticipating results from several of its clinical programs, BioInvent is entering an eventful autumn. In the H1 interim report, CEO Martin Welschof conveys optimism about the company’s future developing novel cancer treatments.– The second quarter was very busy and highly productive, and we will continue this momentum into the second half of the year.Read the article at biostock.se: https://www.biostock.se/en/2024/09/bioinvent-anticipates-a-continued-data-rich-2024/ This is a press

BioStock: Prolight Diagnostics advances towards validation of test for myocardial infarction diagnostics

Prolight Diagnostics’ report for the second quarter marks significant progress in developing the point-of-care analysis system Psyros. Not least, the company received a British grant of SEK 17 million, allowing them to initiate a pre-validation study on whole blood samples from patients with suspected myocardial infarction. The first results from the study are expected in the fourth quarter of 2024.Read the full article at biostock.se : https://www.biostock.se/en/2024/09/prolight-diagnostics/ This is a press release from BioStock - Connecting Innovation &

Repurchase of Truecaller B shares in week 35, 2024

During 26 August 2024 and 30 August 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 190,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 28 May 2024. The share buyback programme will run between 28 May up until the 2025 AGM which will be held in May 2025, and is carried out in accordance “Emittentregelverket”. On the Annual General Meeting 2024 the Board was authorized to buy back B-shares up until the

New US Consensus Report supports Nevisense

· Consensus reached by top US clinicians assessing technologies for melanoma detection and management · The report concludes that the Nevisense AI-driven technology can significantly enhance early melanoma detectionSWEDEN, - Sept 02, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], pioneering prevention and prediction in dermatology announces that key US clinicians and scientists reached consensus on Nevisense and how it can significantly enhance the diagnostic assessment and clinical decision-making for early melanoma at point of care. Nevisense is an AI-driven, non-invasive

Gasum to supply Hapag-Lloyd with waste-based bio-LNG in accordance with winning ZEMBA tender

Gasum will bunker Hapag-Lloyd’s container vessels with a total amount of 20,000 mt of bio-LNG during 2025–2026.Energy company Gasum is collaborating with Hapag-Lloyd to supply their container vessels with liquefied biomethane (bio-LNG) during a two-year tender period. Earlier this year, Hapag-Lloyd, one of the world’s leading container shipping companies, won the first tender by the Zero Emission Maritime Buyers Alliance  (ZEMBA) for ocean shipping based on waste-based bio-LNG that achieves at least a 90

RESQUNIT AB (PUBL) Issues Strategic Update and Announces Availability of Comprehensive Business Description Document

Stockholm, September 2, 2024, 08:30 CET — RESQUNIT AB (PUBL) (Nasdaq First North: RESQ) today announced that a comprehensive business description document outlining the company’s strategic direction and new investment focus is now available here and on its website. This document provides an in-depth overview of RESQUNIT AB's operations based on the planned acquisition of the investment operation from Bio Vitos Norge AS (Bio Vitos).Strategic Integration and Future Plans RESQUNIT AB (PUBL) is actively working on integrating and adapting to the investment operations from Bio Vitos into its

There are no items matching the current filter
There are no more items matching the current filter
Back to top